Oscar S.H. Chan

3.5k total citations · 1 hit paper
35 papers, 1.7k citations indexed

About

Oscar S.H. Chan is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Oscar S.H. Chan has authored 35 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Otorhinolaryngology and 14 papers in Oncology. Recurrent topics in Oscar S.H. Chan's work include Head and Neck Cancer Studies (17 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Oscar S.H. Chan is often cited by papers focused on Head and Neck Cancer Studies (17 papers), Lung Cancer Treatments and Mutations (15 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Oscar S.H. Chan collaborates with scholars based in China, Hong Kong and United States. Oscar S.H. Chan's co-authors include Wai Tong Ng, Anne W.M. Lee, Michael C.H. Lee, Amy Chang, Wai Man Hung, Lucy Chan, Cheuk‐Wai Choi, Henry Sze, Rebecca M.W. Yeung and Connie Chan and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Oscar S.H. Chan

32 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era

2014 276 citations Anne W.M. Lee, Wai Tong Ng et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Oscar S.H. Chan

Since Specialization

Citations

This map shows the geographic impact of Oscar S.H. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oscar S.H. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oscar S.H. Chan more than expected).

Fields of papers citing papers by Oscar S.H. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oscar S.H. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oscar S.H. Chan. The network helps show where Oscar S.H. Chan may publish in the future.

Co-authorship network of co-authors of Oscar S.H. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Oscar S.H. Chan. A scholar is included among the top collaborators of Oscar S.H. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oscar S.H. Chan. Oscar S.H. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients with EGFR mutant (m) MET-altered NSCLC receiving tepotinib with an EGFR tyrosine kinase inhibitor (TKI): A case series. 2023 ·Journal of Clinical Oncology ·Xiuning Le, Anna Eisert, Te‐Chun Hsia, Nirmal Vivek Raut, (unknown), Oscar S.H. Chan, Charlotte De Bondt, David Farrugia, Patrizia Froesch, María González‐Cao, Lizza Hendriks, Maximilian J. Hochmair, Julien Mazières, (unknown), Jens Samol, Anthonie J. van der Wekken, Tsung‐Ying Yang, (unknown), Soetkin Vlassak, Gee‐Chen Chang	0
2	ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI 2020 ·Lung Cancer ·Oscar S.H. Chan, Kwok Chi Lam, (unknown), (unknown), (unknown), Amy Chang, Frankie Mo, Ki Wang, Rebecca M.W. Yeung, Tony Mok	49
3	Real-world prevalence of programmed death ligand 1 expression in locally advanced or metastatic non–small-cell lung cancer: The global, multicenter EXPRESS study 2019 ·Lung Cancer ·Manfred Dietel, Н. А. Савелов, (unknown), Patrick Micke, Gilbert Bigras, Toyoaki Hida, José Ramón Antúnez López, Birgit Guldhammer Skov, Georg Hutarew, Luz F. Sua, Hidetaka Akita, Oscar S.H. Chan, Bilal Piperdi, Thomas Burke, Shirin Khambata‐Ford, Anne C. Deitz	102
4	OA07.02 ATOM: A Phase II Study to Assess Efficacy of Preemptive Local Ablative Therapy to Residual Oligometastases After EGFR TKI 2018 ·Journal of Thoracic Oncology ·Oscar S.H. Chan, (unknown), (unknown), (unknown), (unknown), (unknown), Frankie Mo, (unknown), Richie Yeung, Tony Mok	2
5	The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis 2017 ·Clinical Oncology ·Oscar S.H. Chan, Victor Lee, Tony Mok, Frankie Mo, Amy Chang, Rebecca M.W. Yeung	51
6	Comparison of Planning Quality and Efficiency Between Conventional and Knowledge-based Algorithms in Nasopharyngeal Cancer Patients Using Intensity Modulated Radiation Therapy 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Amy Chang, Albert W.M. Hung, (unknown), Michael C.H. Lee, Oscar S.H. Chan, (unknown), (unknown), Wai Tong Ng	127
7	Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era breakdown → 2014 ·Radiotherapy and Oncology ·Anne W.M. Lee, Wai Tong Ng, Lucy Chan, Wai Man Hung, Connie Chan, Henry Sze, Oscar S.H. Chan, Amy Chang, Rebecca M.W. Yeung	276
8	Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4? 2014 ·Oral Oncology ·Henry Sze, Lucy Chan, Wai Tong Ng, Albert W.M. Hung, Michael C.H. Lee, Amy Chang, Oscar S.H. Chan, (unknown), Rebecca M.W. Yeung, Anne W.M. Lee	26
9	Maintenance therapy in advanced non-small cell lung cancer: a prime-time for change? 2013 ·Chinese Medical Journal ·Oscar S.H. Chan, (unknown), Anne Wing Mui Lee	2
10	Staging of nasopharyngeal carcinoma – The past, the present and the future 2013 ·Oral Oncology ·Wai Tong Ng, (unknown), Kwok Hung Au, Oscar S.H. Chan, Anne W.M. Lee	42
11	The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement 2012 ·Oral Oncology ·Anne W.M. Lee, Wai Tong Ng, L.K. Chan, Oscar S.H. Chan, (unknown), Connie Chan, (unknown), Henry Sze, (unknown), T.K. Yau	97
12	Radical radiotherapy for nasopharyngeal carcinoma in elderly patients: The importance of co-morbidity assessment 2011 ·Oral Oncology ·Henry Sze, Wai Tong Ng, Oscar S.H. Chan, (unknown), Lucy Chan, Anne W.M. Lee	36
13	The superiority of hybrid-volumetric arc therapy (VMAT) technique over double arcs VMAT and 3D-conformal technique in the treatment of locally advanced non-small cell lung cancer – A planning study 2011 ·Radiotherapy and Oncology ·Oscar S.H. Chan, Michael C.H. Lee, Albert W.M. Hung, Amy Chang, Rebecca M.W. Yeung, Anne W.M. Lee	55
14	The prognostic value of histological typing in nasopharyngeal carcinoma 2011 ·Oral Oncology ·Florence Cheung, Oscar S.H. Chan, Wai Tong Ng, Lucy Chan, Anne Lee, Siu Wah Pang	35
15	Clinical Outcomes and Patterns of Failure After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Wai Tong Ng, Michael C.H. Lee, Wai Man Hung, Cheuk‐Wai Choi, (unknown), Oscar S.H. Chan, Anne W.M. Lee	216
16	The Superiority of Hybrid-RapidArc Radiotherapy Technique in the Treatment of Advanced Non-small Cell Lung Cancer: A Planning Study 2010 ·International Journal of Radiation OncologyBiologyPhysics ·Oscar S.H. Chan, Albert W.M. Hung, (unknown), Alexander Chang, Rebecca M.W. Yeung, (unknown)	1
17	Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening 2008 ·Familial Cancer ·Wai Tong Ng, Cheuk‐Wai Choi, Michael C.H. Lee, Oscar S.H. Chan, (unknown), Anne W.M. Lee	31
18	Parapharyngeal Extension of Nasopharyngeal Carcinoma: Still a Significant Factor in Era of Modern Radiotherapy? 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Wai Tong Ng, Oscar S.H. Chan, Anne W.M. Lee, (unknown), T. Yau, Wai Man Hung, Michael C.H. Lee, Cheuk‐Wai Choi	29
19	Sensorineural Hearing Loss After Treatment of Nasopharyngeal Carcinoma: A Longitudinal Analysis 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Oscar S.H. Chan, Wai Tong Ng, (unknown), Michael C.H. Lee, Cheuk‐Wai Choi, T. Yau, Anne W.M. Lee, (unknown)	88
20	Metabolic Syndrome after Laparoscopic Bariatric Surgery 2008 ·Obesity Surgery ·Clare Nugent, Chunhong Bai, Hazem Elariny, (unknown), (unknown), (unknown), Mariam Afendy, Oscar S.H. Chan, Angela Wheeler, Arian Afendy, Zobair M. Younossi	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact